HP rolls out ‘Prints in Minutes’ service at Walmart stores
PALO ALTO, Calif. The largest retailer in the United States is revitalizing its photo departments with the installation of a new photo print service.
Walmart inked a deal with HP last week to install the technology company’s retail publishing service, “Prints in Minutes,” across 3,600 stores in the United States by the end of the summer. Customers will be able to take advantage of a fast, high-quality photo print service as well as a broad array of personalized printed merchandise, including calendars and greetings cards and access to images from such brands as Nickelodeon, Warner Bros. and Live Nation.
The “Prints in Minutes” service features the HP Instant Print Solution, a self-serve, front-of-counter system that lets consumers pick up orders for prints and creative products within minutes of ordering or at a later time by using a secure order storage and release feature. The unattended system allows retailers like Walmart to increase photo center traffic and revenue from high-margin products without dedicated labor. The system is powered by the compact and efficient HP Photosmart PM2000e Microlab printer for lab-quality photo output.
Walmart used HP’s “Prints in Minutes” service in a pilot testing, HP said.
“Our agreement with Walmart is another milestone in HP’s drive to help retailers transition from traditional photo services to dynamic publishing centers,” said Vyomesh Joshi, EVP imaging and printing group at HP. “With new customer agreements with many major global retailers, including Tesco, Kmart Australia and now Walmart, we’re bringing consumers new opportunities to conveniently print both personal and branded digital content that is meaningful to them.”
Boehringer Ingelheim’s cancer drug may be ‘next generation’ treatment
RIDGEFIELD, Conn. Data from a late-stage clinical trial of an investigational drug by Boehringer Ingelheim could show that the drug is a “next generation” treatment for cancers of the lungs, head and neck, BI said Friday.
The German drug maker plans to present results of a phase 3 trial of BIBW 2992 at the annual meeting of the American Society of Clinical Oncology in Chicago, which will take place between June 4 and 8.
BIBW 2992 is a pharmaceutical drug that targets the epidermal growth factor receptor and human epidermal receptor 2, also known as EGFR and HER2. Both are proteins that are known to promote the growth of cancer cells. BI said the drug shrank tumors in 22% of head and neck cancer patients, compared with 13% among those taking Eli Lilly’s and Bristol-Myers Squibb’s Erbitux (cetuximab).
The company also reported that the drug showed “significant” ability to fight tumors in patients with non-small cell lung cancer, and that 61% of patients with EGFR mutations had significant tumor shrinkage.
Americans need more faith… in fiber
WHAT IT MEANS AND WHY IT’S IMPORTANT Not eating enough fiber doesn’t kill you. But the disease states that result from a poor fiber diet do. Not a believer? Then you too may be a victim of IDS (irrational disbelief syndrome), the tongue-in-cheek faux condition that Fiber One touts as being the No. 1 cause behind America’s lack of fiber faith.
(THE NEWS: Lack of fiber in Americans’ diet caused by negative perception, Mintel finds. For the full story, click here)
The IDS condition may have been created out the mind of a General Mills marketer, but the lack of fiber in the typical American’s diet is real. As are the disease states that fiber deficiency can trigger such disease states as cardiovascular disease, colorectal and esophageal cancer, obesity, atherosclerosis, and coronary heart disease. A number of other less severe conditions is also correlated with a low fiber intake — elevated cholesterol levels, hemorrhoids, constipation, diarrhea and flatulence.
The real conclusion you can draw from this study is that Americans don’t know what they don’t know — fiber doesn’t taste good; only people suffering from digestive issues need to supplement their diets with fiber; all fibers are created equal. False, false and false. And that spells opportunity for a whole host of manufacturers in moving the needle around fiber education.